Cardiology

Top Story

FDA designates recall of external defibrillator as Class 1

March 27, 2017

The FDA has designated Phillips Healthcare’s product recall of an external monitor and defibrillator as a Class 1 recall, the most serious kind. The recall affects 47,362 devices manufactured and distributed between 2004 and 2016.

Battery and electrical connection issues in the device (HeartStart MRx Monitor/Defibrillator), used to pace patients with bradycardia or shock patients with sudden cardiac arrest, may prohibit it from charging, powering up and delivering electrical shock therapy, according to a MedWatch report from the FDA.

Meeting NewsPerspective

TAVR in bicuspid aortic stenosis more effective with newer-generation devices

March 27, 2017
WASHINGTON — Treatment of bicuspid aortic stenosis with transcatheter aortic valve replacement was comparable to transcatheter aortic valve replacement in
Meeting News

High cholesterol levels, no statins linked with increased failure rate after arthroscopic rotator cuff repair

March 27, 2017
SAN DIEGO — Patients with moderate or high cholesterol levels and who were not prescribed statins had a greater risk for failure after arthroscopic rotator cuff…
Meeting News

Cardiac rehab reduces CV events after MI

March 27, 2017
WASHINGTON — Exercise-based cardiac rehabilitation benefits patients who have had an MI in preventing adverse events, according to evidence presented at the
Meeting News

Fuster receives lifetime achievement award from ACC

March 26, 2017
WASHINGTON — The American College of Cardiology granted its lifetime achievement award to Valentin Fuster, MD, PhD, director of Mount Sinai Heart and…
More News Headlines »
Advertisement
Advertisement